Peer-influenced content. Sources you trust. No registration required. This is HCN.
Therapeutic Advances in Musculoskeletal Disease
Early treatment phases may transiently promote immune activation, whereas sustained therapy, by reducing BMI and lowering systemic inflammation, may mitigate this effect.
Cardiology March 13th 2026
Epoch Health
“Use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” — FDA Class II Recall Definition
Cardiology March 10th 2026
Annals of Internal Medicine
The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.
Medical News Today (MNT)
“Less plaque does not necessarily mean low risk in women. Plaque biology and distribution matter, not just total quantity.” — Kevin Shah, MD, MemorialCare Heart & Vascular Institute
MDLinx
The updated “Ritter Rules” reinforce that early recognition and multidisciplinary collaboration are critical to surviving aortic dissection.
Cardiology Advisor
“Discontinuation of statins at pregnancy was not associated with increased maternal cardiovascular risk, including among high-risk women.” — Study investigators, Circulation